TCT-451 Two-year outcomes after revascularization with a biodegradable polymer ultra-thin strut sirolimus eluting stent and a biodegradable polymer biolimus-eluting stent. From the SORT OUT VII trial

Abstract

Polymer materials used for the first and second generation drug-eluting stents (DES) may trigger chronic inflammatory responses that can lead to late adverse outcomes. DES with biodegradable polymers could have the potential to abolish these late events. However, DES with biodegradable polymers may